IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MERCK & CO (MRK), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
LOS ANGELES, CA / ACCESS Newswire / February 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of ...
Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to identify previously secret ...
Merck Foundation Chief Executive Officer (CEO) advanced Cancer Care in Africa by providing 194 Oncology Scholarships in ...
LOS ANGELES, CA / ACCESS Newswire / February 19, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of ...
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder ...
Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, announces a license and research collaboration agreement with MSD (tradename ...
The health care sector is likely reacting to the uncertainty created by the effect of federal budget cuts now being ...
Procter & Gamble Health Limited (P&G Health), the maker of popular healthcare products like Polybion, Cosome, Evion, ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has conditionally approved WELIREG® (belzutifan), Merck’s oral ...
Cencora Inc., a Conshohocken-based wholesale drug distributor, scrubbed a diversity, equity, and inclusion page from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback